Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 of the Best Stocks to Buy for Growth Investors

By Chris Lau, InvestorPlace Contributor

A weak start for stocks in October will create good entry points for growth investors. Here are seven of the best prospects to look at.

Danger Lurks Ahead for LYFT Stock as Markets Continue to Wobble

By Chris Lau, InvestorPlace Contributor

Selling pressure on LYFT stock growing as investors grow impatient over a lack of profitability. A volatile market certainly isn't helping.

Exxon Stock has Strong Upside for Investors in the Energy Sector

By Chris Lau, InvestorPlace Contributor

Weak energy prices are hurting Exxon stock but the setback is just a phase. Energy demand will eventually pick up, sending XOM shares higher.

Get Ready for a Wild Ride With QCOM Stock

By Chris Lau, InvestorPlace Contributor

Qualcomm is stuck in a trading range because of U.S.-China trading relations souring. This is short-sighted. 5G brings growth ahead.

Cronos Stock Is a Buy if You Can Handle the Wild Ride Ahead

By Chris Lau, InvestorPlace Contributor

The deep sell-off in cannabis stocks is not yet over. Cronos stock is getting caught up, too, but long-term investors should hold tight.

Load More